Merkoša sitáhtat
APA-čujuhus (7. p.)
Abo-amer, Y. E., Badawi, R., El-Abgeegy, M., Elsergany, H. F., Mohamed, A. A., Mostafa, S. M., . . . Abd-Elsalam, S. (2020). Quadruple Therapy Offers High SVR Rates in Patients with HCV Genotype 4 with Previous Treatment Failure. Wiley.
Kopierejuvvon čuohpusbeavdái
Kopieren čuohpusbeavdái ii lihkostuvvan
Chicago-čujuhus (17. p.)
Abo-amer, Yousry Esam-Eldin, et al. Quadruple Therapy Offers High SVR Rates in Patients with HCV Genotype 4 with Previous Treatment Failure. Wiley, 2020.
Kopierejuvvon čuohpusbeavdái
Kopieren čuohpusbeavdái ii lihkostuvvan
MLA-čujuhus (9. p.)
Abo-amer, Yousry Esam-Eldin, et al. Quadruple Therapy Offers High SVR Rates in Patients with HCV Genotype 4 with Previous Treatment Failure. Wiley, 2020.
Kopierejuvvon čuohpusbeavdái
Kopieren čuohpusbeavdái ii lihkostuvvan
Muitte dárkkistit čujuhemiid riektatvuođa, ovdal go geavahat daid iežat deavsttas.
